PHARMACOLOGY OF NICOTINE AND ITS THERAPEUTIC USE IN SMOKING CESSATIONAND NEURODEGENERATIVE DISORDERS

Citation
Djk. Balfour et Ko. Fagerstrom, PHARMACOLOGY OF NICOTINE AND ITS THERAPEUTIC USE IN SMOKING CESSATIONAND NEURODEGENERATIVE DISORDERS, Pharmacology & therapeutics, 72(1), 1996, pp. 51-81
Citations number
262
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
01637258
Volume
72
Issue
1
Year of publication
1996
Pages
51 - 81
Database
ISI
SICI code
0163-7258(1996)72:1<51:PONAIT>2.0.ZU;2-0
Abstract
During the last decade, nicotine has been used increasingly as an aid to smoking cessation and has been found to be a safe and efficacious t reatment for the symptoms of nicotine withdrawal. This period has also seen significant advances in our understanding of the mechanisms unde rlying the psychopharmacological responses to nicotine, including, par ticularly, those that have been implicated in nicotine addiction. This paper reviews this decade of progress in the specific context of the therapeutic application of nicotine to the treatment of smoking cessat ion. Other putative future applications, particularly in the treatment of neurodegenerative disorders, are also reviewed. Copyright (C) 1996 Elsevier Science Inc.